Literature DB >> 10191235

A simple and reproducible method for collecting nasal secretions in frail elderly adults, for measurement of virus-specific IgA.

E E Walsh1, A R Falsey.   

Abstract

The standard method for collection of respiratory secretions, by use of a nasal wash (NW) to measure virus-specific IgA, is problematic in frail elderly adults. Therefore, a simplified collection approach using a nasal swab (NS) is described. NW and NS samples were collected from healthy young and frail elderly adults, and IgA titers to respiratory syncytial virus (RSV) fusion and attachment glycoproteins were determined by enzyme immunoassay. Correlation between IgA titers in NW and NS was excellent for each of the antigens (correlation coefficients,.71-.93). In addition, NS results were reproducible when frail elderly subjects were sampled several weeks apart and were nearly equivalent to results from NW samples. The ability to sample nasal secretions by use of an NS when an NW is not technically feasible will facilitate the study of mucosal immunity to RSV as well as the study of mucosal response to candidate RSV vaccines in frail elderly populations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10191235     DOI: 10.1086/314726

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

1.  Collection of nasal secretions for immunological analysis.

Authors:  Jean-Baptiste Watelet; Philippe Gevaert; Gabriele Holtappels; Paul Van Cauwenberge; Claus Bachert
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-10-09       Impact factor: 2.503

2.  Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease.

Authors:  Ann R Falsey; Maria A Formica; Patricia A Hennessey; Mary M Criddle; Wayne M Sullender; Edward E Walsh
Journal:  Am J Respir Crit Care Med       Date:  2005-12-30       Impact factor: 21.405

3.  Rates of hospitalizations for respiratory syncytial virus, human metapneumovirus, and influenza virus in older adults.

Authors:  Kyle Widmer; Yuwei Zhu; John V Williams; Marie R Griffin; Kathryn M Edwards; H Keipp Talbot
Journal:  J Infect Dis       Date:  2012-04-23       Impact factor: 5.226

4.  Viral shedding and immune responses to respiratory syncytial virus infection in older adults.

Authors:  Edward E Walsh; Derick R Peterson; Aja E Kalkanoglu; Frances Eun-Hyung Lee; Ann R Falsey
Journal:  J Infect Dis       Date:  2013-02-04       Impact factor: 5.226

5.  Risk factors for respiratory failure associated with respiratory syncytial virus infection in adults.

Authors:  Coley B Duncan; Edward E Walsh; Derick R Peterson; F Eun-Hyung Lee; Ann R Falsey
Journal:  J Infect Dis       Date:  2009-10-15       Impact factor: 5.226

6.  Comparison of quantitative reverse transcription-PCR to viral culture for assessment of respiratory syncytial virus shedding.

Authors:  Ann R Falsey; Maria A Formica; John J Treanor; Edward E Walsh
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

7.  Swabbing for respiratory viral infections in older patients: a comparison of rayon and nylon flocked swabs.

Authors:  S S Hernes; H Quarsten; E Hagen; A L Lyngroth; A H Pripp; B Bjorvatn; P S Bakke
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-09-18       Impact factor: 3.267

8.  Heat shock protein 70 and anti-heat shock protein 70 antibodies in nasal secretions of patients with chronic rhinosinusitis.

Authors:  Namjil N Tsybikov; Elena V Egorova; Boris I Kuznik; Elena V Fefelova; Eli Magen
Journal:  Allergy Rhinol (Providence)       Date:  2016-01

9.  The burden of respiratory syncytial virus in adults: a systematic review and meta-analysis.

Authors:  M Tin Tin Htar; M S Yerramalla; J C Moïsi; D L Swerdlow
Journal:  Epidemiol Infect       Date:  2020-02-13       Impact factor: 2.451

10.  Clinical Evaluation of Techniques for Measuring Nasal-Specific Immunoglobulin E in Pediatric Patients.

Authors:  Ji Young Ahn; Suk Jin Hong; Bong Seok Choi
Journal:  J Korean Med Sci       Date:  2017-12       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.